Effect of Locally Produced Mango Variety on Glycemic Index

ConditionGlycemic Index and Glycemic Load

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-30

SponsorRehman Medical Institute - RMI

About this trial

This randomized trial aims to assess the glycemic index (GI) of locally available mango varieties in healthy adult participants, using glucose as the reference food. The study will evaluate the postprandial blood glucose response elicited by selected mango varieties and compare it to the response produced by a standard glucose . The objective is to determine whether certain mango varieties have a lower glycemic impact, which may be relevant for dietary planning and public health recommendations.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Healthy non-diabetic adults

Normal fasting blood glucose levels

Willingness to provide informed consent

Disqualifiers

Gastrointestinal, metabolic, or endocrine disorders

Current use of medications affecting blood glucose

Pregnant or lactating women

Smoking or alcohol consumption

Trial design

Design model

Single group

Treatments tested in this trial

Mango (langra)
Other intervention
Participants will consume mango variety A . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.
mango (chaunsa)
Other intervention
Participants will consume mango variety B . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.
MANGO (SINDHRI)
Other intervention
Participants will consume mango variety C . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.

Treatment groups

30 Participants

are divided into 1 treatment group

Group A: Single group (cross over)Active comparator 3 interventions

Trial outcomes

Primary outcomes

Glycemic Index (GI) of Mango Varieties

Glycemic index will be calculated for each mango variety by measuring the postprandial blood glucose response over 120 minutes and comparing the incremental area under the curve (iAUC) to that of a standard glucose reference.

Time frame

0 to 120 minutes after consumption of test food

Secondary outcomes

Peak Blood Glucose Level

Maximum capillary blood glucose concentration observed after consumption of each test food.

Time frame

0 to 120 minutes after consumption

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rehman Medical Institute - RMI

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: